Literature DB >> 22895088

Association between the PRNP 1368 polymorphism and the occurrence of sporadic Creutzfeldt-Jakob disease.

Jolanta Bratosiewicz-Wąsik1, Joanna Smoleń-Dzirba, Annemieke J Rozemuller, Casper Jansen, Wim Spliet, Gerard H Jansen, Tomasz J Wąsik, Paweł P Liberski.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a rare transmissible neurodegenerative disorder. The etiology of sporadic form of CJD remains unsolved. In addition to the codon 129 polymorphism, polymorphisms in the non-coding region of PRNP are considered as important factors in sCJD development. To assess a possible association between PRNP 1368 SNP and sCJD, we compared the genotype, allele and haplotype frequencies of the 1368 SNP among 46 sCJD patients of Dutch origin with the respective frequencies in healthy controls. We detected a significant association between sCJD and 1368T/T genotype. A significant difference was also observed in 1368 alleles' distribution. In the haplotype analysis, haplotype 1368C-129G was associated with decreased risk of sCJD in Dutch population. Our findings support the hypothesis that genetic variations in the regulatory region of the PRNP gene may influence the pathogenesis of sCJD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895088      PMCID: PMC3609072          DOI: 10.4161/pri.21773

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  23 in total

1.  First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases.

Authors:  K Peoc'h; C Guérin; J P Brandel; J M Launay; J L Laplanche
Journal:  Neurosci Lett       Date:  2000-06-02       Impact factor: 3.046

2.  PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease.

Authors:  James E McCormack; Herbert N Baybutt; Dawn Everington; Robert G Will; James W Ironside; Jean C Manson
Journal:  Gene       Date:  2002-04-17       Impact factor: 3.688

3.  Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice.

Authors:  D Westaway; C A Mirenda; D Foster; Y Zebarjadian; M Scott; M Torchia; S L Yang; H Serban; S J DeArmond; C Ebeling
Journal:  Neuron       Date:  1991-07       Impact factor: 17.173

4.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.

Authors:  J Collinge; M S Palmer; A J Dryden
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.

Authors:  Esther A Croes; Behrooz Z Alizadeh; Aida M Bertoli-Avella; Tessa Rademaker; Jeannette Vergeer-Drop; Bart Dermaut; Jeanine J Houwing-Duistermaat; Dorothee P W M Wientjens; Albert Hofman; Christine Van Broeckhoven; Cornelia M van Duijn
Journal:  Eur J Hum Genet       Date:  2004-05       Impact factor: 4.246

8.  Analysis of sequence variability of the bovine prion protein gene (PRNP) in German cattle breeds.

Authors:  Petra Sander; Henning Hamann; Ina Pfeiffer; Wilhelm Wemheuer; Bertram Brenig; Martin H Groschup; Ute Ziegler; Ottmar Distl; Tosso Leeb
Journal:  Neurogenetics       Date:  2004-01-15       Impact factor: 2.660

9.  Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD.

Authors:  E Golanska; K Hulas-Bigoszewska; E Rutkiewicz; M Styczynska; B Peplonska; M Barcikowska; J Bratosiewicz-Wasik; P P Liberski
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

Review 10.  Genetics of prion disease.

Authors:  Sarah Lloyd; Simon Mead; John Collinge
Journal:  Top Curr Chem       Date:  2011
View more
  4 in total

1.  Three sporadic cases of Creutzfeldt-Jakob disease in China and their clinical analysis.

Authors:  Xingbang Wang; Na Li; Aifen Liu; Lin Ma; Peiyan Shan; Wenjing Jiang; Qun Zhang
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

2.  Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Emma Jones; Holger Hummerich; Emmanuelle Viré; James Uphill; Athanasios Dimitriadis; Helen Speedy; Tracy Campbell; Penny Norsworthy; Liam Quinn; Jerome Whitfield; Jacqueline Linehan; Zane Jaunmuktane; Sebastian Brandner; Parmjit Jat; Akin Nihat; Tze How Mok; Parvin Ahmed; Steven Collins; Christiane Stehmann; Shannon Sarros; Gabor G Kovacs; Michael D Geschwind; Aili Golubjatnikov; Karl Frontzek; Herbert Budka; Adriano Aguzzi; Hata Karamujić-Čomić; Sven J van der Lee; Carla A Ibrahim-Verbaas; Cornelia M van Duijn; Beata Sikorska; Ewa Golanska; Pawel P Liberski; Miguel Calero; Olga Calero; Pascual Sanchez-Juan; Antonio Salas; Federico Martinón-Torres; Elodie Bouaziz-Amar; Stéphane Haïk; Jean-Louis Laplanche; Jean-Phillipe Brandel; Phillipe Amouyel; Jean-Charles Lambert; Piero Parchi; Anna Bartoletti-Stella; Sabina Capellari; Anna Poleggi; Anna Ladogana; Maurizio Pocchiari; Serena Aneli; Giuseppe Matullo; Richard Knight; Saima Zafar; Inga Zerr; Stephanie Booth; Michael B Coulthart; Gerard H Jansen; Katie Glisic; Janis Blevins; Pierluigi Gambetti; Jiri Safar; Brian Appleby; John Collinge; Simon Mead
Journal:  Lancet Neurol       Date:  2020-09-16       Impact factor: 44.182

Review 3.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

4.  Analyses of the survival time and the influencing factors of chinese patients with prion diseases based on the surveillance data from 2008-2011.

Authors:  Cao Chen; Ji-Chun Wang; Qi Shi; Wei Zhou; Xiao-Mei Zhang; Jin Zhang; Chan Tian; Chen Gao; Xiao-Ping Dong
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.